Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs11549465
rs11549465
0.010 GeneticVariation BEFREE The distribution differences of gene frequencies for rs11549465, rs11549467 and rs1957757 in HIF1A single nucleotide gene polymorphisms for LVH (+) and LVH (-) were statistically significant (p<0.05). 31599436

2019

dbSNP: rs11549467
rs11549467
0.010 GeneticVariation BEFREE The distribution differences of gene frequencies for rs11549465, rs11549467 and rs1957757 in HIF1A single nucleotide gene polymorphisms for LVH (+) and LVH (-) were statistically significant (p<0.05). 31599436

2019

dbSNP: rs1957757
rs1957757
0.010 GeneticVariation BEFREE The distribution differences of gene frequencies for rs11549465, rs11549467 and rs1957757 in HIF1A single nucleotide gene polymorphisms for LVH (+) and LVH (-) were statistically significant (p<0.05). 31599436

2019

dbSNP: rs2074192
rs2074192
0.010 GeneticVariation BEFREE ACE2 tagSNPs rs2074192 and rs2106809 as well as major haplotypes CCGC and TCGT may serve as novel risk markers for LVH in hypertensive patients. 30917908

2019

dbSNP: rs2106809
rs2106809
0.010 GeneticVariation BEFREE ACE2 tagSNPs rs2074192 and rs2106809 as well as major haplotypes CCGC and TCGT may serve as novel risk markers for LVH in hypertensive patients. 30917908

2019

dbSNP: rs28933979
rs28933979
TTR
0.010 GeneticVariation BEFREE Kaplan-Meier analysis demonstrated a significantly higher probability of the composite endpoint in the non-Val30Met group than in the Val30Met group (log-rank test: P = 0.002) and in patients with left ventricular hypertrophy than in patients without left ventricular hypertrophy (log-rank test: P < 0.001). 30284755

2019

dbSNP: rs755492182
rs755492182
0.010 GeneticVariation BEFREE We identified a rare c.740C>T (p.T247M) mutation in ACTN2, encoding α-actinin 2 in a HCM patient, who presented with left ventricular hypertrophy, outflow tract obstruction, and atrial fibrillation. 31680489

2019

dbSNP: rs28935197
rs28935197
0.010 GeneticVariation BEFREE N215S patients showed later symptom onset (males: p< 0.0001, females: p<0.03), later development of left ventricular hypertrophy (LVH) (median survival without LVH: 41 (non-N215S) vs. 64 (N215S) years, p< 0.0001), later development of proteinuria (median survival without proteinuria 43 (non-N215S) vs 71 years (N215S), p< 0.0001), later occurrence of cerebrovascular events (stroke/ Transient Ischaemic Attacks (TIA); median survival without stroke: 74 years (non-N215S) vs. not reached (N215S), p< 0.02), later decline in renal function to GFR <60 ml/min/1.73m2 (median survival: 56 (non-N215S) vs. 72 (N215S) years, p< 0.01), and greater overall survival (median survival 81 (N215S) vs. 66 (non-N215S) years, p< 0.0006). 29621274

2018

dbSNP: rs861539
rs861539
0.010 GeneticVariation BEFREE The XRCC3 241Thr/Met genotype was more frequent in the LVH (+) group than in the LVH (-) group (42.3 vs. 13.7%, χ2 = 7.85, p = 0.0051). 29626209

2018

dbSNP: rs1050606
rs1050606
0.010 GeneticVariation BEFREE In the luciferase experiment, ANXA5 rs1050606 had the most promoter activity in myocardial cells (P < .001).These results showed that ANXA5 rs1050606 was significantly associated with LVH in Chinese EH patients, likely via influencing ANXA5 expression in serum and in myocardial cells. 29095261

2017

dbSNP: rs1349963459
rs1349963459
0.010 GeneticVariation BEFREE The aim of this study was to test the association between a functional polymorphism Glu37Asp (rs2296545) of the renalase gene and left ventricular hypertrophy in a large cohort of patients with aortic stenosis. 29065134

2017

dbSNP: rs2073618
rs2073618
0.010 GeneticVariation BEFREE Thalassemia patients having minor allele of OPG rs2073618, RANK rs75404003 and RANKL rs9594782 SNPs were at high risk for LVH as suggested by high odds ratio of 2.470, 3.783, and 2.148, respectively; however, none of the SNPs tested were statistically significantly associated after applying Bonferroni corrections for multiple testing adjustment. 28244588

2017

dbSNP: rs2296545
rs2296545
0.010 GeneticVariation BEFREE The aim of this study was to test the association between a functional polymorphism Glu37Asp (rs2296545) of the renalase gene and left ventricular hypertrophy in a large cohort of patients with aortic stenosis. 29065134

2017

dbSNP: rs2296545
rs2296545
0.010 GeneticVariation BEFREE The aim of this study was to test the association between a functional polymorphism Glu37Asp (rs2296545) of the renalase gene and left ventricular hypertrophy in a large cohort of patients with aortic stenosis. 29065134

2017

dbSNP: rs4291
rs4291
ACE
0.010 GeneticVariation BEFREE Increased ACE activity explains the significant association of rs4343 and rs4291 polymorphisms with LVH in the carriers. 28513230

2017

dbSNP: rs4343
rs4343
ACE
0.010 GeneticVariation BEFREE Increased ACE activity explains the significant association of rs4343 and rs4291 polymorphisms with LVH in the carriers. 28513230

2017

dbSNP: rs5186
rs5186
0.010 GeneticVariation BEFREE A total of 176 hypertensive patients with a diagnosis of HFpEF were divided to cases with LVH and controls without. rs4343 and rs4291 of angiotensin-converting enzyme (ACE) and rs5186 of angiotensin receptor type 1 were genotyped using PCR-RFLP method. 28513230

2017

dbSNP: rs75404003
rs75404003
0.010 GeneticVariation BEFREE Thalassemia patients having minor allele of OPG rs2073618, RANK rs75404003 and RANKL rs9594782 SNPs were at high risk for LVH as suggested by high odds ratio of 2.470, 3.783, and 2.148, respectively; however, none of the SNPs tested were statistically significantly associated after applying Bonferroni corrections for multiple testing adjustment. 28244588

2017

dbSNP: rs9594782
rs9594782
0.010 GeneticVariation BEFREE OPG rs2073618, RANK rs75404003, and RANKL rs9594782 SNPs may predispose LVH in thalassemia patients. 28244588

2017

dbSNP: rs2070951
rs2070951
0.010 GeneticVariation BEFREE Left ventricular hypertrophy (LVH) was more prevalent in G carriers than AA homozygous for rs5522 but not for rs2070951 in RHTN. 26049084

2016

dbSNP: rs238234
rs238234
0.010 GeneticVariation BEFREE Our results provide evidence that the rs238234 GG genotype in the coding region of CAMTA2 may increase the risk of LVH by affecting the activation of Nkx2.5-dependent transcription. 26886562

2016

dbSNP: rs5522
rs5522
0.010 GeneticVariation BEFREE Left ventricular hypertrophy (LVH) was more prevalent in G carriers than AA homozygous for rs5522 but not for rs2070951 in RHTN. 26049084

2016

dbSNP: rs17168525
rs17168525
0.010 GeneticVariation BEFREE No significant association between the variant rs17168525 and left ventricular hypertrophy in hypertensive patients in a Han Chinese population (P>0.05). 26274321

2015

dbSNP: rs1799998
rs1799998
0.010 GeneticVariation BEFREE Some studies have focused on the relationship between -344C/T polymorphism (rs1799998) in the CYP11B2 gene and LVH, but the results are controversial. 25208931

2015

dbSNP: rs4129218
rs4129218
0.010 GeneticVariation BEFREE This study suggests that rs4129218 on chromosome 12 showed consistent tendency of possibly related loci for LVH independent of ethnic background. 25927456

2015